Susan MacLeman

Ms. Susan E.
MacLeman is a Chairman of Pharmaceutical Industry Competitiveness Task Force, a Chairman-Health Forum at Academy of Technological Sciences & Engineering, an Independent Non-Executive Director at Source Certain International Ltd., a Member at Nsw Innovation & Productivity Council and a Member at Pharmaceutical Industry Working Group.
She is on the Board of Directors at Health Translation Group Ltd., Viral Vector Manufacturing Facility Pty Ltd., Smartways Logistics Holdings Pty Ltd., Australian Academy of Technological Sciences & Engineering, Planet Innovation Pty Ltd., Australian Genomic Cancer Medicine Centre Ltd. and Source Certain International Ltd. Ms. MacLeman was previously employed as an Independent Non-Executive Director by Palla Pharma Ltd., a Non-Executive Chairman by Tali Digital Ltd., a Non-Executive Director by Anatara Lifesciences Ltd., a Chairman by Mtpconnect, a Non-Executive Chairman by Oventus Medical Ltd., an Independent Non-Executive Director by RHS Ltd., a Head-Commercialization by Mesoblast Ltd., a Chief Executive Officer by Progen Pharmaceuticals Ltd., a Chief Executive Officer, Director & MD by Benitec Ltd. (Australia), a Chief Executive Officer by EQiTX Ltd., a Global Vice President by Agenix Ltd., a Member by Pharmaceuticals Industry Council, and a Non-Executive Director by Veski.
She received her undergraduate degree from The University of Queensland, a graduate degree from Deakin University and a graduate degree from Melbourne Business School.